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Abstract
Background: Codon optimization and subcellular targeting were studied with the aim to increase the expression
levels of the SAG178-322 antigen of Toxoplasma gondii in tobacco leaves. The expression of the tobacco-optimized
and native versions of the SAG1 gene was explored by transient expression from the Agrobacterium tumefaciens
binary expression vector, which allows targeting the recombinant protein to the endoplasmic reticulum (ER) and
the apoplast. Finally, mice were subcutaneously and orally immunized with leaf extracts-SAG1 and the strategy of
prime boost with rSAG1 expressed in Escherichia coli was used to optimize the oral immunization with leaf
extracts-SAG1.
Results: Leaves agroinfiltrated with an unmodified SAG1 gene accumulated 5- to 10-fold more than leaves
agroinfiltrated with a codon-optimized SAG1 gene. ER localization allowed the accumulation of higher levels of
native SAG1. However, no significant differences were observed between the mRNA accumulations of the different
versions of SAG1. Subcutaneous immunization with leaf extracts-SAG1 (SAG1) protected mice against an oral
challenge with a non-lethal cyst dose, and this effect could be associated with the secretion of significant levels of
IFN-g. The protection was increased when mice were ID boosted with rSAG1 (SAG1+boost). This group elicited a
significant Th1 humoral and cellular immune response characterized by high levels of IFN-g. In an oral
immunization assay, the SAG1+boost group showed a significantly lower brain cyst burden compared to the rest
of the groups.
Conclusion: Transient agroinfiltration was useful for the expression of all of the recombinant proteins tested. Our
results support the usefulness of endoplasmic reticulum signal peptides in enhancing the production of
recombinant proteins meant for use as vaccines. The results showed that this plant-produced protein has potential
for use as vaccine and provides a potential means for protecting humans and animals against toxoplasmosis.
Background
The use of plants for the large-scale production of het-
erologous proteins is gradually gaining widespread
acceptance and could provide a platform for the cost-
effective production of proteins on an agricultural scale.
In particular, it has been proposed that plant production
for human and animal vaccines may significantly lower
the cost of production of the raw material, especially for
oral vaccination [1,2]. However, low protein yield is a
significant problem limiting the commercial exploitation
and the competition with other heterologous production
methods [3]. In this sense, several approaches have been
developed to increase protein expression in plants. In
particular, techniques such as codon optimization and
subcellular targeting can markedly improve the expres-
sion levels [4].
Toxoplasma gondii is an obligate intracellular parasite
capable of infecting a variety of mammals, including
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usually asymptomatic in healthy individuals. However,
in pregnant women, congenital infection can cause
severe neonatal malformations and ocular complications
in the fetus; and in immunocompromised individuals,
such as AIDS patients and transplant recipients, often
results in fatal encephalitis [6,7]. Toxoplasmosis is also
of veterinary importance, especially in sheep and pigs,
where it often results in abortion, causing considerable
economic losses [8,9]. In addition, the tissue cysts of
T. gondii in meat of infected livestock are an important
source of infection for humans [10,11].
Although a vaccine against human infection with
T. gondii is not yet available, an effective vaccine pre-
venting infection in animals used for human consump-
tion would block the main transmission route to
humans [12]. Also, in the farming industry, a vaccine
against T. gondii m a yb ev a l u a b l et op r e v e n tb o t hf e t a l
infection and reactivation.
Recently, we transiently expressed the surface antigen
1 (SAG1) and granule dense 4 (GRA4) of Toxoplasma
gondii in tobacco leaves [13,14]. SAG1 protein is the
best characterized and the primary vaccine candidate
[13,15-18]. Numerous studies have demonstrated its
vaccine potentialities as a recombinant protein or as a
DNA vaccine [11,19-23]. In fact, a SAG1-specific CD8+
T-cell clone exhibited cytolytic activity against target
cells infected with T. gondii [24]. In an effort to improve
the expression level of SAG1 in plant leaves, in the pre-
sent work, we investigated the effects that codon optimi-
zation and plant cell-compartment targeting have on
SAG1 expression levels using vacuum agroinfiltration.
We also evaluated the efficacy of subcutaneous or oral
immunization with SAG1-expressing leaf extract.
Results
Synthesis of a codon-optimized SAG1 gene
SAG1, previously named P30 (accession no. GQ253098),
is the main surface antigen of T. gondii [25]. In the
parasite, SAG1 is processed before it is loaded to the
plasma membrane, losing the signal peptide and the C-
terminal hydrophobic region, to generate the mature
SAG177-322 version [25]. For this reason, the open
reading frame sequence encoding the native SAG177-322
(nS) was used as a source of codon optimization for
expression in tobacco (Table 1). A total of 57 codons
were altered in the nS sequence to match the codon
usage preferences of Nicotiana tabaccum, yielding an
optimized-plant version of the SAG1 sequence named
oS (Figure 1 and Table 1). The oS gene was synthesized
using a set of overlapping oligonucleotides (Figure 1 and
Table 2). The optimization strategy removed only about
20% of all the infrequently used codons. In addition, in
order to avoid potential negative factors influencing pro-
tein expression, a putative splicing site, a potential plant
polyadenylation signal sequence, consecutive strings of
A + T or G + C nucleotides of 5 bp or more were
removed (Figure 1). The final G + C content of the oS
gene was lowered to 46% and the codon adaptation
index value (CAI) was increased to 0.83 for matching
with tobacco genes as compared to the 0.67 CAI value
of the nS sequence. The nucleotide sequence of the oS
gene (accession no. GU191164) was 92% homologous to
the nS gene. However, the amino acid sequence encoded
by the oS was identical to that of the nS gene to ensure
retention of the antigenicity of the expressed protein.
Construction of the apoplast and endoplasmic reticulum
targeting vectors
The oS and nS sequences were cloned in a pzp200bar
binary vector for plant expression (Figure 2A and Table
1). Both the oS and nS sequences were fused to the
tobacco (Nicotiana tabaccum) AP24 osmotin signal pep-
tide sequence at the N-terminus end to target the
recombinant proteins to the apoplast, generating the
AoS and AnS sequences (Figure 2B and Table 1). Com-
bining the apoplast targeting sequence with an endo-
plasmic reticulum retention signal (KDEL) incorporated
at the C-terminus end the recombinant proteins are
sequestered in the ER of plant cells (KoS and KnS
sequences, Figure 2B and Table 1).
The pzp200bar binary vector, where the AoS, AnS, KoS
and KnS versions were cloned, contains the duplicate
cauliflower mosaic virus 35S promoter (35SCaMV × 2)
with the translational enhancer sequence (Ω)a n dt h e
nopaline synthase (nos) terminator to stop transcription.
Table 1 Summary of Agrobacterium expression constructs used during this study
Vector Insert clone name Protein name cell compartment targeted
pZPVX SAG1 (full-length protein) pZPVXSAG1
a PVXS Cytoplasm
Pzp SAG1 (full-length protein) pApoSAG1
a AS Apoplast
Pzp nS (last 14 codons removed) pAnS AnS Apoplast
Pzp oS (last 14 codons removed and plant-optimized SAG1) pAoS AoS Apoplast
Pzp KnS (last 14 codons removed) pKnS KnS Endoplasmic reticulum
Pzp KoS (last 14 codons removed and plant-optimized SAG1) pKoS KoS Endoplasmic reticulum
a [13]
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(bar gene), which permits the selection of transformed
plants (Figure 2). In addition to these constructions, the
previously pZPVXSAG1 and pApoSAG1 constructs [13],
where SAG1 is expressed as a full-length protein lacking
the signal peptide (SAG177-336: from position 77 to the
end 336), were also used (Table 1).
Transient expression of SAG1 in plants
Vacuum agroinfiltration was used to compare the
expression of SAG1 constructs in plants. Recombinant
Agrobacterium carrying these constructs and the control
pzp200 were used to agroinfiltrate leaves of the Nicoti-
ana tabaccum cv. Xanthi transgenic line X-27-8 [26].
This line expresses high levels of the Tobacco etch virus
(TEV) P1/HC-Pro sequence. Agrobacterium-mediated
transient expression declines sharply as a result of
post-transcriptional gene silencing (PTGS). Certain
plant viruses encode silencing suppressors that may
inhibit PTGS and are used to extend and enhance Agro-
bacterium-mediated transient expression [27]. In a pre-
vious work, SAG1 was successfully expressed in this
transgenic line [13].
SAG1 protein expression was measured at 4 days
post-infiltration by Western blot from three indepen-
dent Agrobacterium infiltrations. In agreement with
our previous work [13], Western blot analysis of infil-
trated tobacco leaf samples demonstrated the success-
ful expression of the 35 kDa SAG1 together with
another specific band of about 19 kDa (Additional file
1A). SAG1 accumulation in tobacco leaves was esti-
mated by Western blot analysis (Additional file 1B)
using the Gel-Pro analyzer program as described in
methods. Agroinflitration with the pKnS vector
5’ATCGAT ATGGGCAACTTGAGATCTTCTTTTGTTTTCTTCCTCCTTGCCTTGGTGACTTATACTTATGCT
H  H  H  H  H 
GCCAGAGGATCT
GGGATCCAC
AAAGATGGAG
CTGAGAACCCGTGGCAG
CACGTTTCC
GTGATCGGACTTATTGGCTCTATCGCAGCTTGTGTCGCG
polyadenilation
TGACAACGCAGACGTTTGTGGTCGGTTGCATCAAGG
T  A  T     T
GTCGCAAGGTGCTCCTA
GCCATG
TTCACTCTCAAGTGCCC TAAAACAGCGCTCACAGAGCCTCCCACTCTTGCGTACTC
GCGGG T
A      A       T     T
ACTACAAGTAGCTGTACATCAAAGGCTGTAACATTGAGCTCCTTGATTCCTGA
GCTGGTGGACGGGGGATTCTGCTAGTCTCGACACGGCAGGCATCAAACTCACAGTTCCAATCGAGAAGTT
CCCCGTGACAACGCAGACGTTTGTGGTCGGTTGCATCAAGGGAGAC
T  T
GCACAGAGTTGTATGGTCACGGTGACAGTACAAGCCAGAGCCTCATCGGTCGTCAATAAT
A T T     T  T     C     
ACTCTTGGTCCTGTCAAGTTGTCTGCGGAAGGACCCACTACAATGACCCTCGTGT GCGGG
T        A            T  T  T  T  T
AATCAGTACTGTT CCGGG ACGACGCTGACTGGT TGCAACGAGAAATCGTTCAAAG ATATTTT
GCCAA AATTAA GGTAACGCTTCGAGTGATAAGGGTGCCACGCTAACGATCAAGAAGGAAGCATTT
AAAAA GCGTC ATTATT GGATGCACA GGGGGATCGCCTGAGAAGCATCACTGTACCGTGAAACTGGAGTTT
GCCGGGGC TGCAGGGTCAGC AAAATCGGCTGCGGG AACAGCCAGT CACGTTTCC ATTTTT
GCCATG
TCTGAGAAAGATGAGCTATGACCCGGG KDEL3’
S  E  K  D  E  L  *  SmaI
TGAGATATC
stop3’
* EcoRV
CATCACCATCACCAT
ACCCAACAGGCAAATCTGCCCA
AGCAGAAGATA
GAGAC
CGGTGCAGACAGC
TCAAAGTTCCTCAAGACAAC
CCAGCCGAGTC
C         T T     T          T        T
T  G  T T  A        A     T     T   C     T    
T      G     T  T     A     A        T 
A  A
A   T   G   T  T 
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Figure 1 Characteristics of the synthetic SAG1 gene. Nucleotides sequence of the native SAG1gene including the ClaI site at the start, and
SmaI and EcoRI sites beyond the stop codons. The apoplastic and endoplasmic reticulum signal sequences at 5’ and 3’, respectively, are
indicated in gray letters. The differences between the synthetic gene used in this study and the wild-type gene are denoted below the
nucleotide sequence of the latter. The His-tag coding sequence is indicated as H. Gray boxes indicate consecutive A+T or G+C nucleotides of
5 bp or more.
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Page 3 of 14produced the highest level of SAG1 expression being
the accumulation of the KnS protein 5- and 10-fold
higher than AoS and KoS, respectively (Figure 3A and
Additional file 1C). In fact, the KnS yields were ~1.3
μg per gram of fresh weight (FW), while the AoS and
KoS vectors generated the lowest SAG1 production:
~0.15 μga n d~ 0 . 4μg per gram of FW, respectively
(Figure 3A). On the other hand, the pAnS and pApo-
SAG1 vectors expressed intermediate SAG1 levels (Fig-
ure 3A and Additional file 1C). The apoplast-localized
native protein levels were ~0.7 μg per gram of FW,
near a production 50% lower than that obtained by
pKnS (Figure 3A). Finally, the removal of the C-termi-
nus did not affect its accumulation, when compared
with its full-length (AnS vs. AS) (Figure 3A).
In order to know whether the differences in protein
expression were due to differences in mRNA expres-
sion, a semi quantitative RT-PCR was performed
(Additional file 1D). SAG1 mRNA expression was
measured at 3 days post-infiltration from three inde-
pendent Agrobacterium infiltrations. SAG1 transcript
levels were normalized with the actin transcripts used
as an internal control. To estimate the level of SAG1
mRNA accumulation, the band intensity was quantified
by the Gel-Pro program and normalized to the band
intensity of actin mRNA quantified by the same pro-
gram. Relative mRNA units from the three indepen-
dent Agrobacterium infiltrations were plotted in Figure
3B. Statistical analysis from the data of the three inde-
pendent agroinfiltrations altogether showed that the
level of SAG1 mRNA accumulation among the infil-
trated leaves with the different constructs was similar
(Figure 3B).
Immunogenicity of plant-derived SAG1
As a first approach to study the immunogenicity of the
plant-derived SAG1, C3H/HeN mice were subcuta-
neously immunized with leaf extracts expressing KnS
protein crude extract combined with incomplete Freund
adjuvant (IFA) (SAG1 group). Mice inoculated with
leaves infiltrated with the empty pzp200 plasmid plus
IFA (Control group) were used as controls. A naïve
group was also included as an additional control. To
analyze the immunoprotective value, two weeks after
the last immunization, mice were orally challenged with
an o n - l e t h a ld o s eo fM E 4 9c y s t sa n do n em o n t hl a t e r
the brain parasite burden was measured. The SAG1
group showed a significant reduction in the brain cyst
burden (30%) compared to control and naïve groups
while these two last groups presented a similar brain
parasite load (Figure 4). In order to improve the
immune protection obtained in SAG1 immunized ani-
mals, a prime-boost immunization protocol was assayed.
Both the SAG1 and Control groups were boosted intra-
dermally (ID) with rSAG1 expressed in E. coli plus IFA
(SAG1+boost and Control+boost, respectively). This
protocol resulted in a significant reduction of 46% in
the brain cyst burden compared to the Control+boost
group and of 54% compared to naïve mice (Figure 4).
No significant differences were detected between the
SAG1 and SAG1+boost groups or between the control
and Control+boost groups.
Two weeks after the immunization schedule was com-
pleted, blood samples were collected and analyzed by
ELISA for specific anti-SAG1 responses. Also, cellular
responses were studied in vivo by a DTH reaction and
in vitro by the characterization of the cytokine profile
Table 2 Primers used in the PCR amplification to obtain the optimized SAG1(77-322) sequence
Primer name Length Sequences
AC 26 bp 5’ atcgatatgggcaacttgagatcttc 3’
ERV 39 bp 5’ gatatcTCAcatAgcaaaGatAgaaacAtgaGAAgctgt 3’
SK 57 bp 5’ cccgggtcatagctcatctttctcagacatAgcaaaGatAgaaacAtgaGAAgctgt3’
F1 36 bp 5’ tactcaccAaacagAcaaatctgTccagcTggtact 3’
R1 54 bp 5’ TctgttTggtgagtaAgcaagagtTggaggTtctgtAagAgctgtCttaggAca 3’
F3 30 bp 5’ acaacTcaAacAtttgtTgtTggttgcatc 3’
R3 30 bp 5’ aaaTgtTtgAgttgtAacTggAaacttctc 3’
F4 33 bp 5’ caagcTagagcctcatcTgtTgtcaaCaatgtc 3’
R4 33 bp 5’ AgatgaggctctAgcttgAactgtcacTgtgac 3’
F5 39 bp 5’ ggaccAactacaatgacTctTgtTtgTggTaaagatgga 3’
R5 36 bp 5’ AagAgtcattgtagtTggtccttcAgcagacaactt 3’
F7 48 bp 5’ gtTatCattggatgTacaggTggatcTcctgagaagcatcactgtacT 3’
R7 39 bp 5’ AcatccaatGatAacActCttAgaTtcAgctggaaatgc 3’
F8 48 bp 5’ ggAgctgcaggAtcagcTaaGtcTgctgcAggaacagcTTCtcaTgtttcT 3’
R8 48 bp 5’ tgaTcctgcagcTccAgcaaactcAagtttcacAgtacagtgatgctt 3’
Recognition site for the endonuclease ClaI, EcoRVa n dSmaI indicated underlined in AC, ERV and SK primers, respectively. Specific mutation sites are indicated in
capital letters.
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Page 4 of 14secreted by splenocytes (Figure 5). Although SAG1-
immunized mice showed neither a significant IgG
production compared to the control and naïve groups
(Figure 5A) nor a positive DTH reaction (Figure 5B),
significant levels of IFN-g were detected in supernatants
of spleen cells after in vitro stimulation with rSAG1
(Figure 5C).
On the other hand, SAG1+boost-immunized mice eli-
cited significant Th1 polarized humoral and cellular
responses (Figure 5). Significant levels of specific IgG
were detected compared to all the experimental groups,
with predominant secretion of IgG2a over the IgG1 iso-
type (Figure 5A). SAG1+boost immunized animals also
showed an antigen-specific cell-mediated immunity as
measured by a positive DTH reaction that resulted sig-
nificantly different compared to all the other groups
(Figure 5B). Upon antigen-specific in vitro stimulation,
the levels of IFN-g secretion were higher than in naïve
and control mice (Figure 5C). The inclusion of an ID
boost with rSAG-1 in control animals (Control+boost)
induced an increase in specific IgG levels and DTH
reactivity, but in contrast to the SAG1+boost group,
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Figure 2 Schematic representation of constructs used in the Agrobacterium-mediated transient expression systems.( A )S c h e m a t i c
representation of the expression cassette of intermediate plasmid pBPFΩ7 and the binary plant vector pZP200. (B) Schematic representation of
pAn/oS and pKn/oS construct. An/oSAG1: the native and plant-optimized genes (residues 77 to 322, excluding the signal peptide in the N-
terminus and the 14 hydrophobic amino acids in the C-terminus) fused to the AP24 osmotin signal peptide sequence in the N-terminus for
driving the mature protein to the apoplast. Kn/oSAG1: the native and plant-optimized genes (residues 77 to 322) fused to the AP24 osmotin and
an endoplasmic reticulum retention signal peptide sequences (TCTGAGAAAGATGAGCTAT) in the N-terminus and the C-terminus, respectively, for
accumulation of the recombinant protein in the RE. 35sCaMVx2: duplicated CaMV 35S promoter; T-nos: nopaline synthase terminator sequence;
Ω: translational enhancer sequence; bar: gluphosinate-resistant gene; RB and LB: right and left borders of the T region, respectively; MCS: multiple
cloning site.
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Page 5 of 14these differences did not significantly differ from the
control and naïve groups (Figure 5A, B). Regarding IFN-
g secretion, the Control+boost group presented
increased levels of this cytokine, which resulted similar
to that observed in the SAG1 and SAG1+boost groups,
but not significantly different from control and naïve
mice (Figure 5C).
Considering that T. gondii infects the host through the
gut mucosa, the feasibility of inducing immunogenicity
at this site by the use of transgenic plants in oral vacci-
nation strategies is an interesting tool. Therefore, an
oral immunization protocol was included in this study
using C57BL/6 (H-2d) mice. Three experimental groups
were used: mice orally immunized with SAG1-expres-
sing leaf extract (SAG1), mice orally immunized with
pzp200-infiltrated leaf extracts (Control), and a third
group of mice orally immunized with SAG1-expressing
leaf extracts plus an intradermal boost with rSAG1
expressed in E. coli (SAG1+boost). To evaluate the pro-
tection against T. gondii infection, two weeks after the
vaccination schedule was completed, immunized mice
were orally challenged and the number of T. gondii
brain cysts was analyzed one month later. No protection
was observed in SAG1-vaccinated mice compared to the
control and naïve groups (Figure 6A). In contrast, the
SAG1+boost group presented a significant reduction in
t h ep a r a s i t el o a d( 5 0 % )w h e nc o m p a r e dt ob o t ht h e
SAG1 and control groups (Figure 6A). The number of
brain cysts in the control (Figure 6A and Additional file
2) or PBS+boost (Additional file 2) groups was not dif-
ferent from that obtained in naïve mice. In the SAG1
+boost group, a significant increase in the SAG1-specific
IgGt was observed when compared to the SAG1 and
control groups (Figure 6B). However, we could not
detect significantly increased levels in any of the IgG
isotypes or a DTH positive response in any of the
experimental groups (data not shown).
Discussion
Our group has previously investigated the suitability of a
vacuum infiltration system to express SAG1 in tobacco
leaves [13]. In that study we tested the performance of
three different constructs. Two of them were based on
the PVX amplicon carrying the SAG1 gene and the
other corresponded to pApoSAG1 [13]. Although the
SAG1 accumulation levels were similar in the PVX
amplicon (PVXS) and pApoSAG1 (AS), the use of this
amplicon in transgenic plants is more difficult due to
the induction of post-transcriptional gene silencing
[26,28]. For this reason, in order to improve the nuclear
(A) (B)
Figure 3 Effect of intracellular localization and codon modification on accumulation of SAG1. (A) SAG1 accumulation in tobacco leaves.
The SAG1 band intensity expressed from E. coli and detected by Western blot was estimated to build a quantization calibration curve with
amount standards. The leaf-expressed SAG1 band intensity detected by western blot was estimated using “Gel-Pro analyzer” and compared with
the quantification calibration curve; a = p < 0.05: KnS vs. PVXS and AS, AS vs. KoS, and AnS vs. AoS; b = p < 0.01: PVXS vs. KoS; c = p < 0.001:
AnS vs. KoS, and KnS vs. AoS and KoS. FW: fresh weight, M, molecular weight marker pre strained (Fermenta); (B) Relative amounts of SAG1
transcripts. SAG1 transcript levels were normalized with the actin transcripts used as an internal control using “Gel-Pro analyzer”. Statistical
analysis was performed by one-way analysis of variance (ANOVA) using the Newman-Keuls Multiple Comparison Test.
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vectors containing codon-optimized SAG1 genes and
plant cell compartment-targeting signal sequences were
investigated using transient expression in Nicotiana by
vacuum agroinfiltration. In addition, the new constructs
deleted the DNA sequence encoding the highly hydro-
phobic 14 C-terminal residues that are processed in the
native SAG1 protein [29].
In general, rare codons, AU-rich destabilizing
sequences and putative polyadenylation and splicing sig-
nals may contribute to rapid mRNA decay, thus limiting
the expression of foreign genes in plants. The CAI value
is considered a measure of the expression levels of a
given gene in different organisms. It is believed that
increasing the CAI of a foreign gene results in a high
expression level of their proteins. However, the increase
in the CAI value brings about an increase in the A+T
content, which could decrease mRNA stability and
reduce the protein expression level [30-34]. Recently,
Sou et al. [35] have shown that constructs carrying
optimized sequences, where the A+T content is higher
than 50%, present a protein expression level significantly
lower than the native protein, although the mRNA level
by RT-PCR is similar in all the constructs. The human
papillomavirus type 16 (HPV-16) L1 gene re-synthesized
to reflect human codon usage expresses better than the
native gene, which expresses better than a plant-opti-
mized gene [36]. Thus, the highest expression of human
L1 protein is correlated with a lowest A+T content,
resulting in a better transcription and RNA processing.
Finally, in the codon-optimized PyMSP4/5 antigen from
Plasmodium, the A+T content is reduced from 67% to
53% and the AT-rich regions are disrupted [37,38]. The
constructs that express a reduced A+T gene version are
more efficient in antigen production than native ver-
sions, supporting that the increase in A+T content may
decrease mRNA stability and reduce the protein expres-
sion level [37,38]. In our study, codon optimization
allowed increasing the CAI value and A+T content for
matching with tobacco genes. In the AoS and KoS DNA
sequences, the A+T content (54%) was higher than that
in the AS, AnS and KnS (48%) genes and the CAI value
was also increased to 0.83. Although this optimization
of the SAG1 gene did not significantly modify the
mRNA levels, the plant-optimized SAG1 expression was
significantly lower than KnS, AnS and AS versions.
Based on that, we could infer that plant codon optimiza-
tion negatively affected SAG1 expression, being the yield
of optimized protein extremely low without apparently
affecting the transcript accumulation. However, further
studies should be carried out to shed light on this point.
According to the SAG1 accumulation analysis by wes-
tern blot, we can group the expression systems in three
categories; higher expression (KnS), intermediate expres-
sion (PVXS, AS, AnS) and lower expression (KoS, AoS).
These results indicate that ER retention of SAG1 is
highly positive and that the low expression level of the
KoS version seems to be restricted to the translational
step. Proteolysis is more likely to occur in the apoplast
rather than in the ER [3,4,39,40]. Thus, retention of the
protein in the ER can be used to minimize foreign pro-
tein degradation since the ER provides a relatively pro-
tective environment with molecular chaperones and
stabilizing agents, which results in an increase of protein
stability and an enhanced level of protein accumulation.
On the other hand, SAG1 yield was lower in the cyto-
plasm using PVX amplicon than in the ER using nuclear
expression systems. Besides, the use of PVX amplicon
induces gene silencing in transgenic plants that consid-
erably affects the transgene expression, being the hetero-
logous protein sometimes undetectable. For this reason,
to produce recombinant proteins in transgenic plants,
they must be co-expressed with proteins able to sup-
p r e s st h i sm e c h a n i s m .H o w ever, this co-expression
Figure 4 Protection of C3H/HeN mice against Toxoplasma
infection. Eight- to ten-week-old mice (8/group) were immunized
on days 0, 14, 28 and 42 by subcutaneous injection. Two weeks
after the last boost, mice were challenged by gavages with 20 cysts
of the Me49 strain (LD50). Thirty days after the challenge, the
number of brain cysts in mice was determined. Each bar represents
the group mean ± S.E.M.a = p < 0.05: SAG vs. Control and naïve,
and SAG1+Boost vs. Control+Boost; b = p < 0.01: SAG1+Boost vs.
Control and SAG1+Boost vs. naïve. Control: mice vaccinated with
pzp200-infiltrated leaf extracts, SAG1: pKnS-infiltrated leaf extracts,
Control+Boost: pzp200-infiltrated leaf extracts + rSAG1 prime boost,
SAG1+Boost: mice vaccine with pKnS-infiltrated leaf extracts plus
rSAG1 prime boost. The results represent one of two similar
experiments. Statistical analysis was performed by one-way analysis
of variance (ANOVA) using the Bonferroni’s Multiple Comparison
Test.
Laguía-Becher et al. BMC Biotechnology 2010, 10:52
http://www.biomedcentral.com/1472-6750/10/52
Page 7 of 14makes this procedure rather difficult and little feasible.
Overall, our data indicate that the best choice for plant
expression is the KnS system.
This study also focused on improving the immuniza-
tion strategy with the leaves containing the SAG1
protein and was set up as a proof of concept that plant-
produced T. gondii proteins could possibly be further
developed as candidates for vaccine approaches. Pre-
viously, we had demonstrated that C3H/HeN mice sub-
cutaneously vaccinated with SAG1 expressed in tobacco
leaves showed significant lower brain cyst burdens
compared to the control group [13]. In that work only
the humoral response was analyzed showing that a weak
Th1 polarized response was elicited. To further evaluate
the immunogenic value of plant-produced SAG1 anti-
gen, in the present study we characterized the immune
responses elicited by the extract from leaves infiltrated
with the pKnS using different immunization protocols.
As in our previous study, significant partial protection
was obtained in SAG1 immunized mice compared to
the controls. Although we could not detect specific IgGs
antibodies, SAG1 immunization elicited a Th1 cellular
A)
B) C)
Figure 5 Humoral and cellular response in C3H/HeN vaccinated mice. (A) Determination of specific anti-rSAG1 humoral response in C3H/
HeN mice. Serum IgG profile in immunized mice determined by ELISA. IgGt: a = p < 0.01: SAG1+Boost vs. Control+Boost; b = p < 0.001: SAG1
+Boost vs. Control, SAG1 and naïve; IgG2a: a = p < 0.001 SAG1+Boost vs. Control, SAG1, Control+Boost and naïve; IgG1: b = p < 0.01 SAG1
+Boost vs. Control, SAG1 and naïve. Values for each serum sample were determined in duplicate. (B) Delayed-type hypersensitivity (DTH) to
Toxoplasma gondii 48 h post-intradermal injection in mice. a = p < 0.05: SAG1+Boost vs. Control+Boost; b = p < 0.01: SAG1+Boost vs. SAG1; c =
p < 0.001: SAG1+Boost vs. Control and naïve. (C) Cytokine production by splenocytes from vaccinated mice. Cells were harvested two weeks
after the last immunization and cultured in the presence of rSAG1 (10μg/ml). Supernatants were collected 72 h later and assessed for the
production of IFN-g by capture ELISA. a = p < 0.05: SAG1 and SAG1+Boost vs. Control and naïve. Control: mice vaccinated with pzp200-
infiltrated leaf extracts, SAG1: pKnS-infiltrated leaf extracts, Control+Boost: pzp200-infiltrated leaf extracts + rSAG1 prime boost, SAG1+Boost: mice
vaccine with pKnS-infiltrated leaf extracts plus rSAG1 prime boost. Results are expressed as the means value ± S.E.M and represent one of two
similar experiments. Statistical analysis was performed by one-way analysis of variance (ANOVA) using the Bonferroni’s Multiple Comparison Test.
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in splenocyte supernatants. A vaccine candidate against
toxoplasmosis has to primarily elicit a Th1 humoral
response and especially increase IFN-g levels, since this
cytokine is one of the main mediators in host resistance
to T. gondii [41]. In our case, no specific-humoral
response was detected and this could be due to the fact
that SAG1 protein possesses conformational B-cell epi-
topes [22,42]. Therefore, as the SAG1 present in the leaf
extracts stimulated only a cellular immune response
which do not require conformational correct antigen
folding [41], it could be hypothesize that this protein,
although it had been dialyzed prior to immunization,
could not be correctly folded. In addition, SAG1 pre-
sented post-translational modifications as glycosylpho-
sphatidylinositol (GPI) additions during its maturation
in the parasite [25]. Although in our case it remains to
be elucidated whether this post-translational modifica-
tion occurred during KnS maturation, it has been pre-
viously shown that the GPI anchoring motifs does not
affect the elicitation of antibody and T-cell responses
against this protein [22].
Although our main goal in this study was to evaluate
whether plant-derived SAG1 was immunoprotective, we
also included a prime-boost protocol with a recombi-
nant SAG1 expressed in bacteria in order to see if we
could improve the immunoprotection. Even though the
inclusion of a boost increased the protection from 30%
to 46% compared to their respective controls and naïve
group, the protection observed between these two pro-
tocols was not significantly different. The protection
observed in the prime-boosted mice is consistent with
the significant Th1 humoral and cellular immune
responses elicited.
The fact that only with the inclusion of a boost immu-
nization a humoral response was induced, is in agree-
ment with the results observed by Wang et al. [37], who
obtained specific antibodies only when plants expressed
PyMSP4/5 antigen from Plasmodium primed mice
where boosted with DNA. It is worth mentioning that
the rSAG1 boost immunization induced significant
humoral and cellular responses capable of protecting
mice against infection, only when mice were previously
primed with the SAG1 expressing leaf extracts (SAG1
+boost) and not with control extracts (Control+boost).
Although similar immune responses were elicited by the
Control+boost and SAG1 groups (without the boost),
partial protection was only observed in this last group.
This protective effect could be attributed to the signifi-
cant levels of IFN-g obtained in the SAG1 group. Never-
theless, whether NK or CD8+ T cell cytotoxic activity
was induced by the immunization protocols, remains to
be elucidated. All these results suggest that immuniza-
tion with tobacco leaves expressing SAG1 is a reliable
system to generate immunity, which could be boosted
by heterologous prime-boost inoculation regimens.
Given that T. gondii gains entry into the body through
the intestinal mucosa, an efficient stimulation of the
(A) (B)
Figure 6 Humoral response in orally immunized C57BL/6(H-2d) mice and protection assay after a challenge with T. gondii cysts.( A )
Cyst number per brain. a = p < 0.05: SAG1+Boost vs. SAG1, Control and naïve. (B) Determination of specific anti-rSAG1 humoral response in
C57BL/6 (H-2d) mice. Specific IgGt titers in sera from vaccinated mice were determined by ELISA. a = p < 0.001: SAG1+Boost vs. SAG1, Control
and naïve. Control: mice vaccinated with pzp200-infiltrated leaf extracts, SAG1: pKnS-infiltrated leaf extracts, SAG1+Boost: mice vaccinated with
pKnS-infiltrated leaf extracts plus rSAG1 prime boost. Statistical analysis was performed by one-way analysis of variance (ANOVA) using the
Bonferroni’s Multiple Comparison Test. Results are expressed as the means value ± S.E.M and represent one of two similar experiments. Values
for each serum sample were determined in duplicate.
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great importance for developing a vaccine against this
parasite [43]. In this sense, an important purpose of the
present work was to test whether leaf-SAG1 oral vacci-
nation could positively influence the outcome of T. gon-
dii infection. Oral immunization with SAG1-containing
leaves elicited neither evident humoral and cellular
immune responses nor protection. Noteworthy, a proto-
col based on a prime with oral immunizations and a
boost with rSAG1 expressed in bacteria injected intra-
dermally elicited an important protection (~50% reduc-
tion of the cyst burden when compared to control) that
correlated at least with an increased humoral response.
It is evident that oral immunization with the plant-
derived SAG1 protein prior to the E. coli-SAG1
intradermal boost was necessary to elicit significant pro-
tection since immunization with control plant extract
prior to the boost, nor the boost alone were able to eli-
cit a protective effect. Most of the reports based on oral
immunization with plant expressed antigens, elicited a
detectable humoral immune response only when an exo-
genous adjuvant was included in the vaccine formula-
tion and/or high doses of the antigen were used [43-50].
Moreover, some works showed that even using high oral
antigen doses in plant extracts with adjuvant, humoral
and cellular immune responses were only observed
when heterologous prime-boost inoculation regimens
were implemented [35,36,40,51]. Taking all these data
together, our results are encouraging because a low anti-
gen dose without adjuvant was used. Future studies
should consider the evaluati o no faw i d er a n g eo fl e a f
tissue doses using lyophilized leaves [52] and/or the
maximization of the efficacy of the antigen presentation
by using potent oral adjuvants [53-55].
Conclusion
We determined that it was feasible to produce vaccine-
relevant T. gondii SAG1 protein in plants of Nicotiana
spp. by means of transient expression via recombinant
A. tumefaciens. We demonstrated that sequence optimi-
zation showed a not positive impact on protein yield.
The ER targeting improved the native SAG1 protein
expression, and it could be used in oral and subcuta-
neous immunization protocols. SAG1 is one of the most
vaccine-relevant T. gondii proteins, so it expression in
plants could have considerable potential.
Methods
Codon usage analysis
The codon usage data of tobacco plants (Nicotiana
tabaccum) and base composition were obtained from
the CUTG (Codon Usage Tabulated from GenBank)
website http://www.kazusa.or.jp/codon/. The codon
adaptation index (CAI) was used as a parameter to
estimate the degree of codon optimization of a whole
gene [56]. The value of transgene was calculated with
the available software CAI Calculator http://www.cbib.u-
bordeaux2.fr/pise/cai.html using tobacco codon usage
values.
Codon modification of the SAG1 gene
The design of the modified SAG1 gene was based on the
data analysis of codon usage. The appropriate codon
optimization was performed to make its CAI value and
A+T content more similar to the general genes in
tobacco plants. The putative transcription termination
signals (AAUAAA and its variants) and cryptic splicing
sites were also eliminated. Long hairpin loops and A/T
strings were avoided to eliminate possible secondary
structures that could halt the transcription process and
destabilize the mRNA. The sequences and alterations of
the SAG1 gene are presented in Figure 1. Synthesis of
the modified SAG1 ORF (residues 77 to 322, excluding
the signal peptide in the N-terminus and the 14 hydro-
phobic amino acids in the C-terminus) was carried out
by the overlapping extension PCR method using the ser-
ies of overlapping oligos shown in Table 2. The first
step consisted of six amplification reactions with pair-
wise combinations of the following overlapping sense
and antisense primers with their positions in Figure 1
using plasmid pApoSAG177-336 as template [13]. In the
following steps, the connected products were amplified
by PCR using the previously amplified PCR product as a
template. The final full-length products were cloned
into the pGemT-Easy vector (Promega). The native
SAG1 (residues 77 to 322) was also amplified by PCR
from plasmid pApoSAG177-336 and cloned into the
pGemT-Easy vector. To ensure that the gene had been
amplified without introducing nucleotide errors, both
strands were sequenced using primers that were specific
for the T7 and SP6 promoters. The synthetic and native
genes were appended with the AP24 osmotin signal pep-
tide sequence in the N-terminus for driving the mature
protein to the apoplast, and with an endoplasmic reticu-
lum retention signal (TCTGAGAAAGATGAGCTAT)
in the C-terminus for the recombinant protein accumu-
lation in the ER. In addition, two restriction sites, ClaI
and EcoRV, were added into the N-terminus and C-ter-
minus, respectively, for the apoplastic versions, and ClaI
and SmaI were added into the N-terminus and C-termi-
nus, respectively, for the ER versions (Figure 1).
Construction of plant expression vector and
Agroinfiltration
The full-length modified and native SAG1 genes with
different signal peptide sequences were sub-cloned in
the expression cassette of intermediate plasmid
pBPFΩ7 between the duplicate CaMV 35S promoter
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Finally, the entire expression cassette, containing the
35sCaMV × 2, the translational enhancer sequence
(Ω), the modified and native sag1 coding sequence and
t-NOS, was released and ligated into the binary plant
vector pZP200. Agrobacterium tumefaciens strain
GV3101 (Rif
R Gm
R) was transformed with construc-
tions pnS, poS, pKnS and pKoS (Table 1) using the
freeze-thaw method for transformation of Agrobacter-
ium tumefaciens [57]. Cultures were grown shaking at
30°C to exponential phase (OD600 approx. 0.8) in LB
broth containing the appropriate antibiotics. Leaves
from 2-4 week-old Nicotiana tabaccum v Xanthi plants
were infiltrated by vacuum infiltration [58]. Leaves
were submerged into the bacterial suspension and sub-
jected to a vacuum of 290 kPa for 5-10 min, with
occasional agitation to release trapped air bubbles. The
vacuum was released rapidly (approx. 10 kPa). The
leaves were placed adaxial side down into Petri dishes
containing wet Whatman paper for 4 d (23°C/16 h
photoperiod).
Total soluble protein extraction and Western blot analysis
Tobacco leaves were homogenized in liquid nitrogen
with a mortar and a pestle by the addition of an extrac-
tion urea buffer (8 M urea, 0.1 M NaH2PO4, 0.01 M
Tris-HCl, pH 8.0) in order to solubilize the antigen. The
extract was centrifuged at 3000 rpm for 20 min and the
supernatant collected and used for expression analyses.
For the immunization process, the supernatant was dia-
lyzed against PBS 1X eliminating the urea.
For Western blot analysis, plant extracts were incu-
bated at 100°C for 5 min in loading buffer [59], sepa-
rated by SDS-PAGE (15% gel) and transferred onto
nitrocellulose membranes using an Electro-transfer unit
(Bio-Rad). The membranes were sequentially incubated
with rabbit polyclonal anti-SAG1 antibody (1:500) and
alkaline phosphataseconjugated goat anti-rabbit IgG
(1:5,000; Sigma). After washing, the reaction was devel-
oped by the addition of nitroblue tetrazolium/5-bromo-
4-chloro-3-indolyl phosphate (NBT/BCIP) substrate.
Prestained protein (Fermenta) was included in Western
blots as molecular weight markers. To estimate the
SAG1 accumulation in tobacco leaves E. coli-derived
SAG1 (rSAG1) of known concentration was also sepa-
rated in an SDS-PAGE (15% gel) and detected by Wes-
tern blot (Additional file 1B). The band intensity of
purified rSAG1 detected by Western blot was estimated
with the “Gel-Pro analyzer” software (Media Cyber-
netics) and used as a standard to build a calibration
curve. The leaf-expressed SAG1 band intensity detected
by Western blot was also estimated using the same soft-
ware and compared with a calibration curve obtained by
the band intensity of rSAG1. This strategy allowed us to
have an estimation of the concentration of SAG1
expressed in leaf extracts. SAG1 accumulation in
tobacco leaves was estimated by Western blot analysis
using “Gel-Pro analyzer” as SAG1 μg per percentage of
total soluble protein (TSP).
RT-PCR analysis
Total RNA was isolated from frozen material using Tri-
zol (Gibco) following the manufacturer’s instructions.
RNA (3-5 μg) was reverse-transcribed using oligo (dT)18
primer (Invitrogen) and the SuperScript™ Synthesis Sys-
tem for RT-PCR (Invitrogen). PCR was performed for
30 cycles for both SAG1 and actin using an initial dena-
turation step at 94°C for 2 min, followed by 30 dena-
turation (30 s at 94°C), annealing (30 s at 65°C) and
extension (1 min at 72°C) cycles. After the last cycle, a
final extension was carried out for 10 min at 72°C. PCR
products were visualized on 1.2% (w/v) agarose gels
using a UV light transilluminator. Oligonucleotides 5’-
acgcacagagttgtatgg-3’ (SAG1F), 5’-tatcactcgaagcgttacc-3’
(SAG1R), 5’-ctggcataatgttgcacttgac-3’ (ActF) and 5’-
tgcggtggacaatggaaggac-3’ (ActR) were used as primers
for amplification of the SAG1 and actin coding
sequences, respectively. SAG1 transcript levels were nor-
malized with the actin transcripts used as an internal
control using “Gel-Pro analyzer” (Media Cybernetics).
Immunization of mice
Female C3H/HeN (H-2k) and C57BL/6 (H-2b) mice
obtained from the Instituto de Investigaciones Biotecno-
lógicas (IIB), Buenos Aires, Argentina, were kept in a
pathogen-free environment. The animals were housed
according to the NIH Guide for the Care and Use of
Laboratory Animals. C3H/HeN mice are resistant to the
acute phase of infection by T. gondii resulting in brain
cyst formation, whereas C57BL/6 mice are sensitive and
die 8- 10 days after the oral challenge. Although C3H/
HeN presents an intermediate susceptibility to T. gondii
infection and C57BL/6 is highly sensitive, both are good
to produce brain cysts at low parasite doses.
Mice (8 per experimental group) were immunized
with four doses of infiltrated leaf extracts, without
enrichment or purification, containing the equivalent of
approximately 200 ng of SAG1 emulsified in complete
(1
st dose) or incomplete (2
nd -4
th doses) Freund’sa d j u -
vant (CFA or IFA) by subcutaneous injection at two-
week intervals (SAG1 group). The control group was
injected with leaf extracts infiltrated with not trans-
formed Agrobacterium plus adjuvant (Control group).
Two additional groups were included: one of them was
vaccinated as SAG1 group and two weeks later mice
were boosted intradermally (ID) with 0.4 μgo fr S A G 1
expressed in E. coli emulsified in IFA (SAG + boost
group); the other group was injected as the Control
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trol + boost group).
For oral immunization, three groups of eight C57BL/6
(H-2d) mice were deprived of food and water for 2 h
prior to each vaccine dose and then gavaged with 200 μl
of plant extract. The SAG1 group received four doses of
SAG1-plant extract (200 ng of SAG1 approx.) without
adjuvant at one-week interval using an animal feeding
needle. The control group received four doses of leaf
extracts infiltrated with not transformed Agrobacterium.
The SAG1 + boost group was immunized as the SAG1
group and one week later, mi c ew e r eI Db o o s t e dw i t h
0.4 μg of rSAG1 expressed in E. coli emulsified in IFA.
PBS + boost group received four doses of PBS and one
week later, mice were ID boosted with 0.4 μgo fr S A G 1
expressed in E. coli emulsified in IFA. In all these
experiments a non-immunized group (naïve) was
included.
Two weeks after the last immunization, blood was col-
lected from the tail vein and sera were stored at -20°C
u n t i la n a l y z e df o rt h ep r e s e n c eo fs p e c i f i ca n t i b o d i e s .
Pre-immune serum samples were used as negative
controls.
Measurement of antibody responses
Antigen-specific antibodies were analyzed by enzyme-
linked immunosorbent assay (ELISA) as previously
described [13]. Microtiter plates (Immuno Plate Maxi-
sorp; Nunc) were coated with rSAG1 at 5 μg/ml. Goat
anti-mouse immunoglobulin G (IgG)-horseradish perox-
idase conjugate was used as a secondary antibody (Jack-
son Immunoresearch Laboratories), or goat anti-mouse
IgG1- or IgG2a-horseradish peroxidase conjugates
(Pharmingen) were used for isotype analysis. Immune
complexes were revealed with OPD and optical density
was read at 450 nm with an automatic ELISA reader
(Dynatech MR4000). The negative control serum sam-
ples included in the assay had values lower than the cut
off.
Measurement of delayed-type hypersensitivity (DTH)
response
T. gondii-specific delayed-type hypersensitivity (DTH)
responses were quantified using a 48-hour in vivo hind
footpad swelling assay. Two weeks after the last immu-
nizing dose, the right footpad from each mouse was
injected with 30 μl of PBS containing 50 μgo fT L A .
Forty eight hours after challenges, the increase in hind
footpad swelling was quantified with a dernier caliper.
Results were corrected for prechallenge thickness. The
mice selected for DTH responses were not used for any
other assay.
Cytokine analysis
Spleens were aseptically removed from 4 C3H/HeN
mice per group two weeks after the last injection. Sin-
gle-cell preparations were obtained by crushing spleens
through stainless steel meshes followed by suspension in
erythrocyte lyses buffer (0.15MNH4Cl, 1.0 M KHCO3,
0.1 mM EDTA, pH 7.2). The viability of the cells used
in the experiments was always higher than 80%, as mea-
sured by trypan blue exclusion (Sigma). The cells were
then suspended in RPMI 1640 medium (Life Technolo-
gies) supplemented with 10% fetal bovine serum
(GIBCO), 2-mercaptoethanol (final concentration, 5 ×
10
-5 M), penicillin (100 U/ml), and streptomycin (100
μg/ml).
Supernatants from cultured splenocytes (10 × 10
6/ml)
were collected after 72 h of stimulation with rSAG1 (10
μg/ml) and stored at -70°C. The concentrations of
secreted IFN-g was measured by capture ELISA (Phar-
mingen, BD Biosciences) as specified by the manufac-
turer. Briefly, microtiter plates (Immuno Plate Maxisorp;
Nunc) were coated overnight at 4°C with capturing rat
anti-mouse IFN-g monoclonal antibodies (Pharmingen)
diluted in 0.1 M Na2HPO4 (pH 9). Wells were washed
thoroughly with PBS-Tween 20 0.05%. Empty binding
sites were blocked by 2 h of incubation at 37°C with 1%
bovine serum albumin. Supernatants from culture cells
were tested in duplicate at 100 μl, and serial dilutions of
recombinant murine IFN-g (Pharmingen) were used at
15-4000 pg/ml for the standard curve. After incubation
for 1 h at 37°C, washed plates were incubated with rat
biotynilated anti-mouse IFN-g monoclonal antibodies
(Pharmingen) for 1 h. Streptavidin peroxidase conjugate
(Sigma) diluted 1:1000 was then added to the washed
wells and allowed to react for 30 min. Bound complexes
were detected by a solution of 0.15% H2O2- 0.15%
orthophenylene diamine (Sigma) in citrate (0.1 M) -
phosphate (0.1 M) buffer (pH 4.5). Absorbance was read
at 450 nm in an automatic ELISA reader (Dynatech
MR4000). The sensitivity limits for the assays were 20
pg/ml for IFN-g.
Challenge infection
C3H/HeN and C57BL/6 mice were orally infected with
20 ME49 tissue cysts (sublethal dose) two weeks after
the last immunization. Mice were observed daily for
mortality. One month after the challenge, mice were
sacrificed and their brains removed. Each brain was
homogenized in 2 ml of PBS with a dounce tissue grin-
der. The mean number of cysts per brain was deter-
mined by observation under an optical microscope, by
counting four samples of 20 μl aliquots of each homoge-
nized brain.
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Statistical analysis was carried out with the Prism 5.0
Software (GraphPad, San Diego, CA) using t’ student
test or one-way analysis of variance (ANOVA). Values
of p < 0.05 were considered significant.
Additional material
Additional file 1: SAG1 accumulation in tobacco leaves. (A) Western
blot analysis of SAG1 from infiltrated tobacco leaves. Soluble protein
samples were electrophoresed on a 15% SDS-PAGE gel and blotted onto
a nitrocellulose membrane. The membrane was probed with a rabbit
polyclonal anti-SAG1. Coomassie blue was used as a control of the
soluble protein samples loaded, which were estimated around 100 μgo f
total soluble protein by Bradford’s assay. The western blot results
presented are representative of three independent experiments; (B)
Western blot of SAG1 from 300, 200, 100 and 50 μg of PVXS extracts and
from E. coli-derived SAG1 of known concentration (10, 20 and 30 ng of
rSAG1 quantified by Bradford’s assay). (C) The SAG1 band intensity
expressed from E. coli and detected by Western blot was estimated to
build a quantization calibration curve with amount standards. The leaf-
expressed SAG1 band intensity detected by western blot was estimated
using “Gel-Pro analyzer” and compared with the quantification calibration
curve; a = p < 0.05: KnS vs. PVXS and AflS, AS vs. KoS, and AnS vs. AoS; b
= p < 0.01: PVXS vs. KoS; c = p < 0.001: KnS vs. AoS and KoS, and AnS
vs. KoS. (D) Agarose gel of RT-PCR products obtained with primers
SAG1F and SAGR and ActF and ActR. The RT- PCR results presented are
representative of three independent experiments. GV: pzp200- infiltred
leaf extracts; PVXS: pZPVXSAG1-infiltrated leaf extracts; AS: pApoSAG1-
infiltrated leaf extracts; AnS and AoS: pAnS and pAoS-infiltrated leaf
extracts, respectively; KnS and KoS: pKnS and pKoS-infiltrated leaf extracts,
respectively. Arrows indicate the bands of 35 kDa and 19 kDa detected
with the anti-SAG1 antibody in the plant extract expressing SAG1. M:
prestained protein molecular marker.
Additional file 2: Protection assay after challenge with T. gondii
cysts in orally immunized C57BL/6 (H-2d) mice. Eight- to ten-week-
old mice (8/group) were immunized on days 0, 7, 14 and 21 by oral
vaccination. Two weeks after the last boost, mice were challenged by
gavage with 20 cysts of the Me49 strain (LD50). Thirty days later, the
number of brain cysts in mice was determined. Control: mice orally
vaccinated with pzp200-infiltrated leaf extracts, PBS+Boost: mice orally
inoculated with 3 doses of PBS and a final intradermal boost with rSAG1.
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